NM_032167.5:c.154G>A
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4
The NM_032167.5(SNX29):c.154G>A(p.Val52Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000173 in 1,613,916 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032167.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SNX29 | ENST00000566228.6 | c.154G>A | p.Val52Ile | missense_variant | Exon 4 of 21 | 5 | NM_032167.5 | ENSP00000456480.1 | ||
SNX29 | ENST00000564111.5 | n.216G>A | non_coding_transcript_exon_variant | Exon 4 of 8 | 2 | |||||
SNX29 | ENST00000568949.1 | n.254G>A | non_coding_transcript_exon_variant | Exon 3 of 3 | 3 | |||||
SNX29 | ENST00000569801.5 | n.154G>A | non_coding_transcript_exon_variant | Exon 4 of 6 | 4 | ENSP00000457085.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152168Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000119 AC: 3AN: 251432 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1461748Hom.: 0 Cov.: 30 AF XY: 0.0000248 AC XY: 18AN XY: 727170 show subpopulations
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152168Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74332 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.154G>A (p.V52I) alteration is located in exon 1 (coding exon 1) of the SNX29 gene. This alteration results from a G to A substitution at nucleotide position 154, causing the valine (V) at amino acid position 52 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at